ABM insider files Form 144 to sell 3,567 shares on NYSE for $165k

Rhea-AI Filing Summary

ABM Industries (ABM) filed a Form 144 reporting a proposed sale of 3,567 shares of common stock through Merrill Lynch on the NYSE, scheduled approximately for 10/01/2025, with an aggregate market value of $164,973.75. The filing shows 61,233,895 shares outstanding, and the shares to be sold were entirely acquired through issuer equity compensation: grants and vesting events dated 09/11/2020 and 01/07–01/10/2025 totaling 3,567 shares. The filer reports no securities sold in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Full compliance with Rule 144 disclosure requirements including broker, quantity, and acquisition details
• All shares to be sold were acquired via equity compensation and are itemized with acquisition dates and types

Negative

• None.

Insights

Securities Analyst

TL;DR Routine insider sale notice for equity compensation shares totaling 3,567 shares; no recent sales reported.

The Form 144 documents a planned brokered sale of 3,567 ABM shares, representing a small notional value (~$165k) relative to total outstanding shares (61.2M). All shares were acquired via equity compensation vesting events between 2020 and early 2025, indicating this is execution of employee/insider liquidity rather than a market-disrupting disposition. The absence of sales in the prior three months and the required compliance statements reduce immediate regulatory concern. Impact on float and liquidity is immaterial given company size.

Corporate Governance Expert

TL;DR Proper Rule 144 disclosure of planned insider sale; filings align with standard governance and compliance practices.

The disclosure provides the necessary items: broker, quantity, aggregate value, acquisition dates, and nature of acquisition (equity compensation). This transparency supports governance norms for executive/insider transactions. There is no indication in the form of material non-disclosure or atypical payment arrangements. From a governance perspective, the filing is routine and meets regulatory expectations for insider liquidity events.

10/01/2025 - 04:01 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	3567	164973.75	61233895	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/11/2020	Vesting of performance share award	ABM INDUSTRIES INC /DE/			227	09/11/2020	Granted as part of issuer equity compensation plan
Common Stock	01/07/2025	Vesting of restricted stock unit award	ABM INDUSTRIES INC /DE/			360	01/07/2025	Granted as part of issuer equity compensation plan
Common Stock	01/08/2025	Vesting of performance share award	ABM INDUSTRIES INC /DE/			1837	01/08/2025	Granted as part of issuer equity compensation plan
Common Stock	01/09/2025	Vesting of restricted stock unit award	ABM INDUSTRIES INC /DE/			802	01/09/2025	Granted as part of issuer equity compensation plan
Common Stock	01/10/2025	Vesting of restricted stock unit award	ABM INDUSTRIES INC /DE/			341	01/10/2025	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ABM's Form 144 report for 10/01/2025?

The filing reports a proposed sale of 3,567 ABM common shares through Merrill Lynch on the NYSE on 10/01/2025, totaling $164,973.75.

How many ABM shares outstanding are noted in the Form 144?

The Form 144 lists 61,233,895 shares outstanding.

How were the shares being sold acquired according to the filing?

All 3,567 shares were acquired through equity compensation vesting (performance share awards and restricted stock unit awards) between 09/11/2020 and 01/10/2025.

Did the filer report any sales of ABM securities in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

Who is the broker executing the proposed sale?

The broker named in the filing is Merrill Lynch at 225 Liberty St, New York, NY, and the sale is to occur on the NYSE.